Schildkraut, Joellen M <br/><br/>
Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jan 2002 
 - 32-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/94.1.32  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Contraceptives, Oral, Hormonal--pharmacology<br/>Estrogens--administration & dosage<br/>Female<br/>Humans<br/>Logistic Models<br/>Middle Aged<br/>Ovarian Neoplasms--epidemiology<br/>Progestins--administration & dosage<br/>Risk